Legal & General Group’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-962
| Closed | -$739 | – | 3508 |
|
|
2025
Q1 | $739 | Hold |
962
| – | – | ﹤0.01% | 3373 |
|
|
2024
Q4 | $1.23K | Hold |
962
| – | – | ﹤0.01% | 3386 |
|
|
2024
Q3 | $1.99K | Hold |
962
| – | – | ﹤0.01% | 3399 |
|
|
2024
Q2 | $3.67K | Hold |
962
| – | – | ﹤0.01% | 3394 |
|
|
2024
Q1 | $4.56K | Hold |
962
| – | – | ﹤0.01% | 3307 |
|
|
2023
Q4 | $4.11K | Hold |
962
| – | – | ﹤0.01% | 3339 |
|
|
2023
Q3 | $2.97K | Hold |
962
| – | – | ﹤0.01% | 3390 |
|
|
2023
Q2 | $4.33K | Buy |
+962
| New | +$4.33K | ﹤0.01% | 3378 |
|
|
2022
Q2 | – | Sell |
-3,914
| Closed | -$27K | – | 3625 |
|
|
2022
Q1 | $27K | Hold |
3,914
| – | – | ﹤0.01% | 3156 |
|
|
2021
Q4 | $49K | Buy |
3,914
+956
| +32% | +$12K | ﹤0.01% | 3037 |
|
|
2021
Q3 | $92K | Buy |
2,958
+1,841
| +165% | +$57.3K | ﹤0.01% | 2872 |
|
|
2021
Q2 | $32K | Buy |
1,117
+69
| +7% | +$1.98K | ﹤0.01% | 3114 |
|
|
2021
Q1 | $45K | Buy |
1,048
+44
| +4% | +$1.89K | ﹤0.01% | 2845 |
|
|
2020
Q4 | $72K | Sell |
1,004
-60,485
| -98% | -$4.34M | ﹤0.01% | 2684 |
|
|
2020
Q3 | $1.85M | Buy |
+61,489
| New | +$1.85M | ﹤0.01% | 1791 |
|